Asia-Pacific artificial tears market is estimated to grow modestly at a CAGR of around 5.5% during the forecast period. The major countries which will contribute in the market are China, India, and Japan. China is the biggest market for artificial tears market. The aging population in the region predominantly in Japan and China is one of the key driving factors in Asia-Pacific. Owing to the aging population, the prevalence of eye diseases is expected to increase, thereby increasing the demand for artificial tears in the region during the forecast period. It is expected that by 2050, approximately 8 in 10 people of the older population globally is expected to reside in less developed regions, as per United Nations Economic and Social Commission for Asia and the Pacific (United Nations ESCAP).

Asia-Pacific artificial tears market has been primarily driven due to a rapidly growing aging population, and significant growth in cataract and glaucoma surgery in the region. Moreover, rising air pollution in the region is also one of the major factors affecting the ocular surface that leads to irritation and dry-eye disease. Moreover, the rising burden of the ageing population is a major risk factor that increases the chances of having dry-eye disorder among the older population. For instance, according to United Nations ESCAP, in 2016, nearly 12.4% of the population in Asia-Pacific was 60 years and above. However, it is expected to reach over a quarter or 1.3 billion by 2050. 

The companies which are contributing to the growth of Asia-Pacific artificial tears market include Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Services Inc., Carl Zeiss Meditec AG, Nidek Co., Ltd., and Topcon Corp. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. For instance, in June 2018, Nidek Co., Ltd. launched the RS-3000 advance 2 optical coherence tomography. This instrument is exclusively designed for comprehensive imaging and analysis of the retina and glaucoma. In May 2018, the company launched LSFG-RetFlow Laser Speckle Flowgraphy. It is an instrument that is used for the measurement of ocular blood that will aid in the treatment of glaucoma and retinocortical vascular disease.

Research Methodology

The market study of Asia-Pacific artificial tears market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for drug manufacturers, healthcare providers, government organizations for overall market analysis, and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Asia-Pacific Artificial Tears Market Research and Analysis by Type
2. Asia-Pacific Artificial Tears Market Research and Analysis by Delivery Method
3. Asia-Pacific Artificial Tears Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the Asia-Pacific artificial tears market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific artificial tears market.
• Insights about market determinants which are stimulating the Asia-Pacific artificial tears market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.